Yanru Wang

This early-stage study is testing a new type of CAR-T cell therapy for people with B-cell blood cancers (like certain leukemias and lymphomas) that have come back or stopped responding to standard treatments. The therapy uses donor immune cells that are specially designed to find…

This early-stage study tests a new treatment called RN1701 for people with B-cell lymphoma that has come back or stopped responding to standard therapy. RN1701 uses specially engineered immune cells from a donor to target and kill cancer cells. The main goals are to check if the …